Pharmaceutical Care Management Association v. United States Department Of Health And Human Services et al.

Why this Matters:

The plaintiffs challenge price transparency regulations requiring health insurers to disclosure internal pricing data and negotiated rates in a machine-readable format and prescription drug pricing data—arguing that such requirements violate the Administrative Procedure Act. Broad health care transparency and disclosure measures can help facilitate more informed health care decisions for consumers, promote more high value care, and potentially lower health care prices.

Potential Impact:

Preventing the federal government from crafting price transparency regulations and promote greater public disclosure could lead to consumers losing a valuable tool to make informed decisions and potentially face higher health care prices.